![\"](\"https:\/\/www.goodrxmedicine.com\/blog\/wp-content\/uploads\/2023\/04\/connected-1024x536.webp\")
Preclinical studies show that Sildenafil can significantly improve memory and cognition. They gave either Tadalafil, Sildenafil, or another type of medication to these groups.
Sildenafil users were 69%<\/a> less likely to develop Alzheimer’s after six years.
Researchers<\/a> created a stem cell-derived Alzheimer’s brain cell model to study Viagra’s effects.
They discovered that Sildenafil reduced Tau Protein Hyperphosphorylation in the model.
The medicine also accelerated the growth of brain cells.
Animal trials in 2020 yielded similar results. The dosage of Viagra<\/a> for Alzheimer’s disease can differ.
For four weeks, mice were given 7.5 mg\/kg sildenafil once a day. The dose improved Tau and
Amyloid pathology as well as memory.
Alzheimer’s patients’ Hippocampus<\/a> spontaneous neural activity decreased with 50 mg of Sildenafil.
An older animal trial looked into the benefits of Sildenafil for brain health.
The drug improved mice’s brain abilities, suggesting it could treat Alzheimer’s Disease (AD).
According to 2022 reports<\/a>, Sildenafil (Viagra) may not treat Dementia.
These findings on Dementia and Viagra contradict previous research.
Researchers found that these drugs do not reduce AD and related Dementia risk.
Researchers examined AD and Dementia risk in two groups of people with PAH.<\/p>\n\n\n\n
PDE5 inhibitors did not reduce AD or related Dementia risk in the Sildenafil Alzheimer’s study.<\/p>\n\n\n